Matches in SemOpenAlex for { <https://semopenalex.org/work/W4307757079> ?p ?o ?g. }
- W4307757079 abstract "Women with breast cancer are at risk for the development of sarcopenia and occurrence of fractures. The initial and periodic screening of these conditions can prevent the risks of disability, poor quality of life, and death. The present study investigated the association between sarcopenia phenotypes and fracture risk, assessed by the Fracture Risk Assessment Tool (FRAX) in women with breast cancer.Cross-sectional study. It included women aged between 40 and 80 years, diagnosed with Luminal subtype breast cancer, with time of diagnosis ≤ 12 months, who had not started endocrine therapy, did not have metastasis, had not been treated for another malignancy, and had no recurrences. Sociodemographic, habits and lifestyle, clinical, anthropometric, and body composition variables were considered. Muscle strength, skeletal muscle mass, and physical performance were investigated using handgrip strength (HGS), appendicular skeletal muscle mass index (ASMI), and Timed Up and Go test (TUGT), respectively. Fracture risk was assessed using FRAX. Multiple linear regression models were conducted to verify the association between exposure variables and sarcopenia phenotypes. A significance level of p < 0.05 was adopted for all tests using the SPPS 25.0 program.Sixty-two women with a mean age of 58.1 ± 10.4 years were evaluated. Of these, 66.1% self-declared to be non-white, 41.9% and 71.0% did not consume alcohol or smoke, respectively, and 61.3% were insufficiently active. A total of 45.2% had clinical stage II carcinoma and 65.5% had the invasive breast carcinoma histological subtype. There was a predominance of adequacy of HGS (88.7%), ASMI (94.5%), and TUGT (96.8%), as well as low risk of hip fractures (85.5%) and major fractures (82.3%). HGS remained associated with FRAX hip fractures (p = 0.007) and FRAX major fractures (p = 0.007) in the adjusted models, while ASMI was associated with body mass (p < 0.001).Low muscle strength was the sarcopenia phenotype that remained associated with fracture risk in women with breast cancer, independently of sociodemographic factors, level of physical activity, and clinical factors. In addition to the assessment of probable sarcopenia, this measurement may point out the risk of fractures." @default.
- W4307757079 created "2022-11-05" @default.
- W4307757079 creator A5014176590 @default.
- W4307757079 creator A5017525249 @default.
- W4307757079 creator A5030525769 @default.
- W4307757079 creator A5058220401 @default.
- W4307757079 creator A5060689748 @default.
- W4307757079 creator A5077728350 @default.
- W4307757079 creator A5080217720 @default.
- W4307757079 date "2022-11-01" @default.
- W4307757079 modified "2023-10-01" @default.
- W4307757079 title "Muscle strength is associated with fracture risk obtained by fracture risk assessment tool (FRAX) in women with breast cancer" @default.
- W4307757079 cites W1829077072 @default.
- W4307757079 cites W1830918957 @default.
- W4307757079 cites W1964891491 @default.
- W4307757079 cites W1972338829 @default.
- W4307757079 cites W1974105832 @default.
- W4307757079 cites W1974704788 @default.
- W4307757079 cites W2006478466 @default.
- W4307757079 cites W2008305834 @default.
- W4307757079 cites W2012937904 @default.
- W4307757079 cites W2042264212 @default.
- W4307757079 cites W2110396808 @default.
- W4307757079 cites W2110467562 @default.
- W4307757079 cites W2127164938 @default.
- W4307757079 cites W2160239283 @default.
- W4307757079 cites W2345515755 @default.
- W4307757079 cites W2411932037 @default.
- W4307757079 cites W2475870294 @default.
- W4307757079 cites W2555207714 @default.
- W4307757079 cites W2796428104 @default.
- W4307757079 cites W2800928300 @default.
- W4307757079 cites W2811037321 @default.
- W4307757079 cites W2883998785 @default.
- W4307757079 cites W2896759482 @default.
- W4307757079 cites W2897513125 @default.
- W4307757079 cites W2919362726 @default.
- W4307757079 cites W2935518418 @default.
- W4307757079 cites W2938526389 @default.
- W4307757079 cites W2944176453 @default.
- W4307757079 cites W2957186036 @default.
- W4307757079 cites W2974171230 @default.
- W4307757079 cites W2975594789 @default.
- W4307757079 cites W2978926748 @default.
- W4307757079 cites W2995536476 @default.
- W4307757079 cites W3009850686 @default.
- W4307757079 cites W3011896336 @default.
- W4307757079 cites W3023458025 @default.
- W4307757079 cites W3033196399 @default.
- W4307757079 cites W3036364406 @default.
- W4307757079 cites W3037796085 @default.
- W4307757079 cites W3040712032 @default.
- W4307757079 cites W3120464378 @default.
- W4307757079 cites W3121023166 @default.
- W4307757079 cites W3122102058 @default.
- W4307757079 cites W3125293553 @default.
- W4307757079 cites W3136769243 @default.
- W4307757079 cites W3160097198 @default.
- W4307757079 cites W3184590038 @default.
- W4307757079 cites W3209938014 @default.
- W4307757079 cites W3216722244 @default.
- W4307757079 cites W4206941025 @default.
- W4307757079 cites W4255103055 @default.
- W4307757079 cites W4283778098 @default.
- W4307757079 cites W4302435679 @default.
- W4307757079 doi "https://doi.org/10.1186/s12885-022-10203-4" @default.
- W4307757079 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36320019" @default.
- W4307757079 hasPublicationYear "2022" @default.
- W4307757079 type Work @default.
- W4307757079 citedByCount "3" @default.
- W4307757079 countsByYear W43077570792023 @default.
- W4307757079 crossrefType "journal-article" @default.
- W4307757079 hasAuthorship W4307757079A5014176590 @default.
- W4307757079 hasAuthorship W4307757079A5017525249 @default.
- W4307757079 hasAuthorship W4307757079A5030525769 @default.
- W4307757079 hasAuthorship W4307757079A5058220401 @default.
- W4307757079 hasAuthorship W4307757079A5060689748 @default.
- W4307757079 hasAuthorship W4307757079A5077728350 @default.
- W4307757079 hasAuthorship W4307757079A5080217720 @default.
- W4307757079 hasBestOaLocation W43077570791 @default.
- W4307757079 hasConcept C121608353 @default.
- W4307757079 hasConcept C126322002 @default.
- W4307757079 hasConcept C143998085 @default.
- W4307757079 hasConcept C1862650 @default.
- W4307757079 hasConcept C2776214593 @default.
- W4307757079 hasConcept C2776541429 @default.
- W4307757079 hasConcept C2776886416 @default.
- W4307757079 hasConcept C2777525943 @default.
- W4307757079 hasConcept C2780140570 @default.
- W4307757079 hasConcept C2780221984 @default.
- W4307757079 hasConcept C2994343686 @default.
- W4307757079 hasConcept C530470458 @default.
- W4307757079 hasConcept C71924100 @default.
- W4307757079 hasConceptScore W4307757079C121608353 @default.
- W4307757079 hasConceptScore W4307757079C126322002 @default.
- W4307757079 hasConceptScore W4307757079C143998085 @default.
- W4307757079 hasConceptScore W4307757079C1862650 @default.
- W4307757079 hasConceptScore W4307757079C2776214593 @default.
- W4307757079 hasConceptScore W4307757079C2776541429 @default.
- W4307757079 hasConceptScore W4307757079C2776886416 @default.